A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors
Clinical trial NCT03775850 · COMPLETED
Trial details
- NCT number
- NCT03775850
- Sponsor
- Evelo Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2021-06-30
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.